From the Reddit post earlier!

So, the company took it upon itself, to get off the imposed hold. It had to. It had no choice. It had the rights to the best CCR5 blockade on Earth. It had an obligation to humanity to do everything in its power to get this drug to market. The drug poses no risk to humans. There are no side effects at the dosages tested. The only risk it poses is to Big Pharma itself. The risk is to their wallets.

The company has distanced itself from its prior CEO and from the prior CEO of its prior CRO. The company rid itself of many employees that were around who had contributed to the disdain the authority held against it. The company eradicated all means by which to advertise. ProActive Videos, Christine Corrado, Press Releases and conference call mania all were halted. So, it got the hold lifted unbelievably. They could not beat this drug by any other means except by imposition of the clinical hold. They had to sideline the drug. This is how the game is played. So CytoDyn rose to the challenge, but while they were playing checkers, CytoDyn played chess.

So now, we find that the drug is on its way up again, and this time, for an entirely new indication. It is not going after HIV or COVID or even cancer, but rather it is going up against Inflammation and Immune Activation. But this time, it is not being sidelined, it is no longer handcuffed, it is no longer behind bars. No, this time, it is respected for what it is capable of. They looked at the data of the NASH trial. They saw its anti-inflammatory capacity.

Why? Because those in charge of the drug's approval have taken leave, have left and have gone elsewhere. They have recused themselves of the case. Let's hope their bosses have done the same, because if not, the threat still remains, but if so, this drug proves itself as the greatest threat to their shady practices in disease treatment methods.